liposomal glutathione and nad NAD+ Liposomal NAD+

Pyridoxine can reduce the effect of levodopa if not combined with a decarboxylase inhibitor

Initially, we find that expression of G2019S LRRK2 or WT ArfGAP1 alone markedly and equivalently reduce neurite length by 35-40% compared to WT LRRK2 or control (empty vector) neurons ( Fig

Milacic M, Beavers D, Conley P, Gong C, Gillespie M, Griss J, et al

In a review published last year, Sikiric and his colleagues describe BPC-157 as a drug like no other: In animal models, it counteracts symptoms akin to those of Parkinsons, Alzheimers, and schizophrenia

For friske individer er implikasjonen mer subtil mulig forbedring av motivasjon, fokus og motorisk koordinasjon

BMI indicates body mass index